Key Record Dates
ClinicalTrials.gov Identifier: | NCT02919969 |
---|---|
Brief Title: | Pembrolizumab in Metastatic Anal Cancer |
First Submitted : | September 2, 2016 |
First Submitted that Met QC Criteria : | September 28, 2016 |
First Posted : | September 30, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | April 27, 2022 |
Last Update Posted : | May 3, 2022 |